Cannabis & Wellness

An ancient herb's revival is more than a wellness trend. It’s a forensic look at a market grappling with sustainability, cultural respect, and a search for authentic calm.

Two women-led Canadian brands are partnering, but the real story isn't the sale. It's a masterclass in resilient, values-driven business for a new era.

A probiotic brand's $1M TikTok Shop event wasn't just a sales blitz. It's a calculated move proving social commerce is the new gateway to retail giants.

A new cannabis dispensary is just the start. See how the Moapa Band of Paiutes are leveraging tribal sovereignty and strategic partnerships to build a new economy.

Central Garden & Pet's latest launch isn't just a cat treat; it's a calculated move into the underserved, high-growth feline calming market. Here's the strategy.

A new report reveals which cannabis brands dominate AI search, just as federal rescheduling creates chaos and opportunity. But with AI often refusing to answer, who wins?

A landmark victory at the 2026 Autoflower World Cup validates 42 Fast Buds' strategic pivot to in-house cultivation, setting a new benchmark for the industry.

Glass House Brands follows a new playbook, splitting its business to chase a NYSE listing. Is this the key that unlocks institutional capital for the entire sector?

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

Foundry Nation's new THC-infused colas tap into nostalgia, but their success hinges on navigating a complex web of consumer trends and looming regulations.

As Grown Rogue restarts a dormant Illinois facility, it’s not just planting seeds—it’s testing a capital-efficient strategy for winning in a crowded market.

Dignitas's recent championship, powered by cognitive supplements, signals a major shift away from energy drinks and toward a new era of player wellness.

Restore Hyper Wellness is using a gamified challenge to keep clients engaged this summer. But is this a new frontier in personal resilience or just savvy marketing?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

With new AI tools for voice, e-commerce, and in-store sales, Dutchie is betting big on automation. But can technology solve the core challenges of a complex market?

Elysium Health's new Creatine+ isn't just a supplement; it's a signal of a massive structural shift where human vitality becomes a core economic asset.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.